Winner Medical Announces Mailing of Definitive Proxy Materials for
Special Meeting of Shareholders
SHENZHEN, China, Nov. 8, 2012 /PRNewswire/ -- Winner Medical Group
Inc. (Nasdaq: WWIN) ("Winner Medical" or the "Company"), a leading
China-based exporter and retailer
of high-quality medical dressings and consumer products made from
100% cotton, today announced the mailing of definitive proxy
materials for the special meeting of its holders of common stock
(the "Special Meeting") in connection with the previously announced
merger under the Agreement and Plan of Merger (the "Merger
Agreement") with Winner Holding Limited ("Parent"), a Cayman Islands exempted company with limited
liability and indirectly wholly-owned by Mr. Jianquan Li, and Winner Acquisition, Inc., a
Nevada corporation and a
wholly-owned, direct subsidiary of Parent. Mr. Jianquan Li is the Company's president, chief
executive officer, chairman of the Company's board of directors and
principal stockholder.
The Special Meeting has been scheduled for Friday at
10 a.m., Shenzhen time, on December 7, 2012 at Winner Industrial Park,
Bulong Road, Longhua, Shenzhen
City, 518109, the People's Republic of
China. Holders of the common stock of the Company as at the
close of business, New York time,
on Friday, October 19th, 2012 (the
"Stockholders") will be entitled to vote at the Special
Meeting.
Stockholders are encouraged to read the Company's definitive
proxy materials in their entirety as they provide, among other
things, a detailed discussion of the process that led to the
proposed merger and the reasons behind the unanimous recommendation
by the board of directors that Stockholders vote "FOR" the
proposal to approve the Merger Agreement. Stockholders who have
questions about the merger, need assistance in submitting their
proxy or voting their shares should contact the Company's proxy
solicitor, Okapi Partners LLC, at +1 (212) 297 0720 or toll-free at
+1 (877) 629 6355, or by email at info@okapipartners.com.
Additional Information
This press release may be deemed to be solicitation material in
respect of the proposals described in the Company's definitive
proxy statement on Schedule 14A and other relevant materials, as
filed by or furnished to the Securities and Exchange Commission
(the "SEC") on Novembe 6, 2012. In addition, on November 6, 2012, certain participants in the
proposed transaction filed with the SEC Amendment No. 3 to a
Schedule 13E-3 transaction statement. INVESTORS AND STOCKHOLDERS
ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THESE MATERIALS
AND OTHER MATERIALS FILED WITH OR FURNISHED TO THE SEC CAREFULLY
WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT
INFORMATION ABOUT PARENT, THE COMPANY, THE PROPOSED MERGER, THE
PERSONS SOLICITING PROXIES IN CONNECTION WITH THE PROPOSED MERGER
ON BEHALF OF THE COMPANY AND THE INTERESTS OF THOSE PERSONS IN THE
PROPOSED MERGER AND RELATED MATTERS. In addition to receiving the
proxy materials by mail, Stockholders will also be able to obtain
these documents, as well as other filings containing information
about the Company, the proposed merger and related matters, without
charge, from the SEC's website (http://www.sec.gov) or at the SEC's
public reference room at 100 F Street, NE, Room 1580, Washington, D.C. 20549. In addition, these
documents can be obtained, without charge, by contacting the
Company at Winner Industrial Park, Bulong Road, Longhua,
Shenzhen City, 518109,
People's Republic of China,
telephone: +86 (755) 2813 8888.
The Company and certain of its directors, executive officers and
other members of management and employees may, under SEC rules, be
deemed to be "participants" in the solicitation of proxies from the
Company's stockholders with respect to the proposed merger.
Information regarding the persons who may be considered
'participant's in the solicitation of proxies will be set forth in
the proxy statement and Schedule 13E-3 transaction statement
relating to the proposed merger as filed with the SEC from time to
time. Additional information regarding the interests of such
potential participants is included in the proxy materials.
About Winner Medical
Winner Medical is a leading China-based exporter and retailer of
high-quality medical dressings and consumer products made from 100%
cotton, according to industry trade association statistics. The
Company has fifteen wholly-owned subsidiaries and three joint
ventures, which manufacture and sell tailored medical dressings and
disposables, as well as non-woven fabric made from natural cotton.
With a vertically integrated supply chain ranging from spinning
fabric to finished goods, the Company provides its customers with a
wide range of high-quality products, from surgical and wound care
to consumer goods in China and
abroad. Its products include those with FDA, CE mark, TUV and other
global standard certifications and the Company holds 54
domestic and international patents. For nine consecutive years, the
Company has ranked as one of the leading medical dressing exporters
in China, with North America, Europe and Japan as its major markets. In addition, the
Company distributes under its own "Winner" and "PurCotton®"
brand names in China. To learn
more about Winner Medical, please visit Winner Medical's website
at: http://winnermedical.investorroom.com.
For investor inquiries, please contact:
Okapi Partners LLC
Phone: +1-212-297-0720
Toll-free:+1-877-629-6355
Email: info@okapipartners.com
Ms. Huixuan (Fiona) Chen
Investor Relations Manager
Phone: +86-755-2806-6858
Email: investors@winnermedical.com
SOURCE Winner Medical Group Inc.